The US Senate has passed its National Defense Authorization Act (NDAA) military spending bill for the fiscal year of 2022, setting the budget at an astronomical $778 billion by a vote of 89 to 10.
Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.
Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.
According to Senate Minority Leader Mitch McConnell (R-Ky.), conservative Americans should feel very confident ahead of the 2022 midterm elections. He rejoiced as the GOP heads into the upcoming New Year in a strong position.
President Biden is ending the year with his approval rating at a new low, according to a high-profile poll Monday that finds the White House reeling from higher prices, the COVID-19 crisis and opposition to his social welfare bill.
Colorado Democratic Governor Jared Polis said on Sunday that President Joe Biden needed to change the way that he talks about vaccines and that the definition of “fully-vaccinated” is likely to be changed in the near future.
West Virginia Sen. Joe Manchin dropped a Christmas bomb on Democrats, announcing on Fox News he will not vote for President Joe Biden’s Build Back Better Act, a massive spending and green energy bill the party has been struggling to pass for months.
U.S. drug agents are expanding operations in China – six years after America’s largest trading partner and global rival emerged as the main source of chemicals used to make highly lethal fentanyl. It’s now claiming 65,000 American lives a year.
